Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Nabs $10M in Series F Round; Mouse Protein Chip Due in April

NEW YORK, Feb. 12 (GenomeWeb News) - Protein biochip company Zyomyx has raised $10 million in a Series F round of private-equity financing, the company said today.


Zyomyx said it plans to use the cash to continue developing its protein chip technology. It expects to launch its Murine Cytokine Biochip in April 2004.

 

CSFB Private Equity led the round with existing investors Alloy Ventures, Lilly BioVentures, Hambrecht & Quist Capital Management, Mediphase Venture Partners, Bio*One Capital, and the Biomedical Sciences investment arm of the Singapore Economic Development Board.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.